ACTRN12612001173886尚未招募未知
For patients with Huntington’s Disease, can repetitive Transcranial Magnetic Stimulation (rTMS) in comparison with sham rTMS, reduce choreic movements.
orth Metropolitan Area Health Service0 个研究点目标入组 60 人开始时间: 2012年11月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Patients who attended that Huntington’s Study Group (HSG) at the Neurosciences Unit, Graylands Hospital, who have choreic movements, and for whom the movements are especially intrusive or poorly controlled, will be offered the option of the rTMS trial.
排除标准
- •History of epilepsy.
- •Metal implants in the head.
研究者
相似试验
进行中（未招募）
1 期
Treatment of Huntington´s disease with OSU 6162 - a pilot studyPatients with Huntington´s diseaseEUCTR2009-015926-13-SESahlgrenska University Hospital24
已完成
2 期
Neuroprotection by Cannabinoids in Huntington's DiseaseHuntington's DiseaseNCT01502046Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal25
已完成
2 期
Effect of PBT2 in Patients With Early to Mid Stage Huntington DiseaseHuntington DiseaseNCT01590888Prana Biotechnology Limited109
进行中（未招募）
1 期
Huntington's Disease Rilmenidine Safety Trial - Huntington's Disease Rilmenidine studyHuntington's DiseaseMedDRA version: 14.1 Level: PT Classification code 10070668 Term: Huntington's disease System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2009-018119-14-GBCambridge University Hospitals NHS Foundation Trust and University of Cambridge16
尚未招募
不适用
Long Term Follow-up Grafted Huntington's Disease PatientsHuntington DiseaseNCT06194006Assistance Publique - Hôpitaux de Paris39